<p>The Bureau of Medicine and Surgery issued a $27,331.92 delivery order to Microgenics Corporation on April 14, 2026, for benzodiazepine reagent kits, with ultimate completion on April 24, 2026.</p>
<p>Place of performance is Fremont, CA. The order is firm fixed price with no set-aside applied. Microgenics Corporation, a clinical diagnostics manufacturer, supplies immunoassay reagent test kits for substance detection and medical screening to federal healthcare and military agencies.</p>
<p>The Department of the Army issued a $12,518.40 delivery order to Microgenics Corporation on April 2, 2026, for MDMA/MDA reagent kits with an ultimate completion date of April 23, 2026.</p>
<p>Place of performance is Fort Meade, Maryland. The order is priced on a firm fixed-price basis and carries no set-aside designation.</p>
The Department of the Army issued a delivery order to Microgenics Corporation on December 10, 2025, for MDMA/MDA reagent kits with a ceiling value of $12,518.40. The order is firm fixed price and matures January 1, 2026. Place of performance is Fort Meade, MD. This delivery order is issued under a parent IDV for MDMA/MDA reagent kits valued at $1,154,822.40. Microgenics Corporation, through its Clinical Diagnostics Division, manufactures immunoassay reagent test kits for clinical toxicology...
This is a $78,091.20 firm fixed price delivery order awarded by the Navy Bureau of Medicine and Surgery to Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation. The contract is for the supply of benzodiazepine reagent kits to support substance abuse testing and treatment programs at military and veteran healthcare facilities. The award is part of a larger indefinite delivery contract that Microgenics holds with the Navy Bureau of Medicine and Surgery, valued at...
<p>The Defense Health Agency issued a delivery order to Microgenics Corporation on June 1, 2026, for MDMA and MDA reagent kits with a ceiling value of $25,036.80. The order is due to be completed by September 1, 2026, and performance takes place at Fort Meade, MD. Pricing is firm fixed price. This is a delivery order against a parent indefinite delivery contract for diagnostic reagent supply.</p>
This is a $40,997.88 firm fixed-price delivery order contract awarded by the Air Education and Training Command (AETC) of the U.S. Air Force to Microgenics Corporation, a subsidiary of Thermo Electron Corporation. The contract is for the supply of benzodiazepine reagent kits, with a performance period running through December 15, 2023. This award is part of Microgenics Corporation's broader portfolio of federal contracts to provide toxicology testing solutions and diagnostic products to...
<p>The Department of the Army Medical Command issued a $22,416 delivery order to Microgenics Corporation on May 26, 2026, for benzoylecgonine (BZE) immunoassay reagent kits supporting forensic toxicology drug testing at Tripler Army Medical Center, Fort Shafter, Hawaii, with an ultimate completion date of September 29, 2026.</p>
<p>Place of performance is Fremont, California. The order is firm fixed price with no set-aside designation.</p>
The Bureau of Medicine and Surgery issued a $5,884.20 delivery order to Microgenics Corporation on May 4, 2026, for benzoylecgonine (BZE) immunoassay reagent kits, with final delivery by May 12, 2026. The order is issued under a single-award indefinite delivery contract for BZE immunoassay reagent kits awarded to Microgenics on March 18, 2026, with a ceiling of $775,453.50 and completion date of March 17, 2031. Place of performance is Fremont, California. This delivery order represents a firm...
<p>The Department of the Army issued a $12,645 delivery order to Siemens Healthcare Diagnostics Inc. on June 1, 2026, for cannabinoid immunoassay reagent kits under a firm fixed price.</p>
<p>Place of performance is Fort Meade, MD. The order carries a ceiling value of $12,645 with an ultimate completion date of June 1, 2026. No set-aside was applied to this delivery order.</p>
<p>The Department of the Army issued a $12,645 delivery order to Siemens Healthcare Diagnostics Inc. on July 1, 2025, for cannabinoid immunoassay reagent kits, with an ultimate completion date of June 10, 2026. Place of performance is Fort Meade, MD. The order carries no set-aside and is priced on a firm fixed price basis.</p>